Abstract
Background and Objective: Angiogenesis is the most important repair process of tissues subjectedto ischemic injury. The present study aims to investigate whether the pro-angiogenic effect of Qiliqiangxin prescription(QL) is mediated through miR-21 signaling.
Methods: Cardiac microvascular endothelial cells (CMECs) were isolated and cultured from 2-3 weeks old SDrats by the method of planting myocardium tissues. The purity was identified by CD31 immunofluorescencestaining. CMECs were then cultured under 1% O2 hypoxia or normoxia condition for 24h in the presence orabsence of QL pretreatment (QL, 0.5mg/ml, 24h). The mimics and inhibitors of miR-21 were transfected intoCMECs. miR-21, HIF-1α, and VEGF expressions of CMECs were then detected by qRT-PCR and/or Westernblot. The proliferation, migration, and tube formation functions of CMECs were assessed using the BrdU assay,wound healing test, and tube formation assay, respectively.
Results: The results showed that compared with the control group, hypoxia significantly upregulated the expressionof miR-21 and impaired CMECs proliferation, migration, and tube formation functions. Compared withthe hypoxia group, QL further upregulated miR-21, HIF-1α, and VEGF expressions, and improved cell proliferation,migration, and tube formation of hypoxic CMECs. These effects of QL were abolished by a knockdownof miR-21. Conversely, treatment with miR-21 mimics further enhanced QL induced changes in hypoxicCMECs.
Conclusion: Results indicate that the pro-angiogenesis effects of QL on hypoxic CMECs are mediated by activatingmiR-21 and its downstream HIF-1α/VEGF pathway possibly.
Keywords:Qiliqiangxin prescription, cardiac microvascular endothelial cells, hypoxia, miR-21, angiogenesis, proliferation.
Current Pharmaceutical Design
Title:Qiliqiangxin Prescription Promotes Angiogenesis of Hypoxic Primary Rat Cardiac Microvascular Endothelial Cells via Regulating miR-21 Signaling
Volume: 27Issue: 26
Author(s):Yanyan Wang*, Jingjing Zhang, Mingqiang Fu, Jingfeng Wang, Xiaotong Cui, Yu Song, Xueting Han, Yuan Liu, Jingmin Zhou*Junbo Ge*
Affiliation:
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 200032, Shanghai,China
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 200032, Shanghai,China
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 200032, Shanghai,China
Keywords:Qiliqiangxin prescription, cardiac microvascular endothelial cells, hypoxia, miR-21, angiogenesis, proliferation.
Abstract:
Background and Objective: Angiogenesis is the most important repair process of tissues subjectedto ischemic injury. The present study aims to investigate whether the pro-angiogenic effect of Qiliqiangxin prescription(QL) is mediated through miR-21 signaling.
Methods: Cardiac microvascular endothelial cells (CMECs) were isolated and cultured from 2-3 weeks old SDrats by the method of planting myocardium tissues. The purity was identified by CD31 immunofluorescencestaining. CMECs were then cultured under 1% O2 hypoxia or normoxia condition for 24h in the presence orabsence of QL pretreatment (QL, 0.5mg/ml, 24h). The mimics and inhibitors of miR-21 were transfected intoCMECs. miR-21, HIF-1α, and VEGF expressions of CMECs were then detected by qRT-PCR and/or Westernblot. The proliferation, migration, and tube formation functions of CMECs were assessed using the BrdU assay,wound healing test, and tube formation assay, respectively.
Results: The results showed that compared with the control group, hypoxia significantly upregulated the expressionof miR-21 and impaired CMECs proliferation, migration, and tube formation functions. Compared withthe hypoxia group, QL further upregulated miR-21, HIF-1α, and VEGF expressions, and improved cell proliferation,migration, and tube formation of hypoxic CMECs. These effects of QL were abolished by a knockdownof miR-21. Conversely, treatment with miR-21 mimics further enhanced QL induced changes in hypoxicCMECs.
Conclusion: Results indicate that the pro-angiogenesis effects of QL on hypoxic CMECs are mediated by activatingmiR-21 and its downstream HIF-1α/VEGF pathway possibly.
Export Options
About this article
Cite this article as:
Wang Yanyan *, Zhang Jingjing , Fu Mingqiang , Wang Jingfeng , Cui Xiaotong , Song Yu , Han Xueting , Liu Yuan , Zhou Jingmin *, Ge Junbo *,Qiliqiangxin Prescription Promotes Angiogenesis of Hypoxic Primary Rat Cardiac Microvascular Endothelial Cells via Regulating miR-21 Signaling, Current Pharmaceutical Design 2021; 27 (26) .https://dx.doi.org/10.2174/1381612826666201005152709
DOI https://dx.doi.org/10.2174/1381612826666201005152709 | Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher | Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
- Targeting Vascular Redox Biology Through Antioxidant Gene Delivery: A Historical View and Current Perspectives
Recent Patents on Cardiovascular Drug DiscoveryD-Amino Acids in Peptides from Animals, Including Human: Occurrence, Structure, Bioactivity and Pharmacology
Current Protein & Peptide Science Contrast Media in Cardiovascular Magnetic Resonance
Current Pharmaceutical DesignExtracellular Vesicles as Drug Delivery Vehicles for Rheumatoid Arthritis
Current Stem Cell Research & TherapyImpact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity
Current Molecular Pharmacology Extra-Hematopoietic Effects of Erythropoietin
Cardiovascular & Hematological Disorders-Drug TargetsThe Role of Dietary Compounds in the Therapy of Nicotine-Induced Osteoporosis
Current Drug Targets Inhibition of Inflammation by a p38 MAP Kinase Targeted Cell Permeable Peptide
Medicinal ChemistryPotential Role of Polyphenols in the Prevention of Cardiovascular Diseases: Molecular Bases
Current Medicinal Chemistry The VHL Tumor Suppressor: Master Regulator of HIF
Current Pharmaceutical Design C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
Current Pharmaceutical DesignMetabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches
Current Pharmaceutical DesignOff-Pump Coronary Artery Bypass Grafting; is it Still Relevant?
Current Cardiology ReviewsThe Newly Proposed Mechanism of Cardiomyocyte Protection of Carvedilol-Anti-Apoptosis Pattern of Carvedilol in Anoxia by Inducing AutophagyPartly through the AMPK/mTOR Pathway
Letters in Drug Design & DiscoveryFood-derived Peptides as Promising Neuroprotective Agents: Mechanismand Therapeutic Potential
Current Topics in Medicinal Chemistry Pulmonary Arterial Hypertension
Current Vascular PharmacologyThe Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke
Current NeuropharmacologyPattern Recognition Receptors and Control of Innate Immunity: Role of Nucleic Acids
Current Pharmaceutical Biotechnology Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia
Mini-Reviews in Medicinal ChemistryA Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury
Current Neuropharmacology
[8]ページ先頭